Temozolomide is an Oral Active DNA Alkylating Agent for Kinds of Cancers Research
Glioma, the most prevalent primary malignant tumor of the central nervous system. Glioblastoma (GBM) is the most aggressive subtype of glioma. The current standard of care for GBM involves radiotherapy…